These two clinical signs are also present in subjects with MEGCANN (3-methylglutaconic aciduria with cataracts, neurologic involvement and neutropenia), which is caused by mutations in CLPB, an ATP-dependent refoldase (dissagregase) of the mitochondrial intermembrane space. The gene discussed is CLPB; the disease is Decreased total neutrophil count.